-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PrEP-001 in Rhinovirus Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PrEP-001 in Rhinovirus Infections report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PrEP-001 in Rhinovirus Infections Drug Details: PrEP-001 (JNJ-43260295) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ruvembri in Obesity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ruvembri in Obesity report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ruvembri in Obesity Drug Details: BIO-101 (SARCONEOS) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NVCoV-2 in Respiratory Syncytial Virus (RSV) Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NVCoV-2 in Respiratory Syncytial Virus (RSV) Infections report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NVCoV-2 in Respiratory Syncytial Virus (RSV) Infections Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NVCoV-2 in Middle East Respiratory Syndrome (MERS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NVCoV-2 in Middle East Respiratory Syndrome (MERS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NVCoV-2 in Middle East Respiratory Syndrome (MERS) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Molnupiravir in Liver Failure (Hepatic Insufficiency)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Molnupiravir in Liver Failure (Hepatic Insufficiency) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Molnupiravir in Liver Failure (Hepatic Insufficiency) Drug Details: Molnupiravir...
-
Product Insights
NewLepu Medical Technology (Beijing) Co Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Lepu Medical Technology (Beijing) Co Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Lepu Medical Technology (Beijing) Co Ltd (Lepu Medical) is a medical technology company. It offers medical devices, pharmaceutical APIs and Covid-19 test products. Its products portfolio includes interventional accessories, coronary stents, dilatation balloon catheters, mechanical heart valves, electrophysiology catheters, occlusion devices, pacemakers, in vitro diagnostic equipment and DSA systems, biomarkers and surgical staplers. The company's Covid-19...
-
Product Insights
Likelihood of Approval Analysis for Seasonal Influenza
Overview How likely is it that the drugs in Seasonal Influenza will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Seasonal Influenza Overview Seasonal influenza, commonly referred to as "the flu", is...
-
Product Insights
Likelihood of Approval Analysis for Influenza A Virus, H1N1 Subtype Infections
Overview How likely is it that the drugs in Influenza A Virus, H1N1 Subtype Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Influenza A Virus, H1N1 Subtype Infections Overview H1N1...
-
Product Insights
Likelihood of Approval Analysis for Swine Influenza
Overview How likely is it that the drugs in Swine Influenza will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Swine Influenza Overview Swine influenza is an infection caused by any of...
-
Product Insights
NewSanofi Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Sanofi Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Sanofi is a healthcare company, which is engaged in the discovery, development, manufacturing and marketing of a wide range of medicines and vaccines. Its portfolio includes medicines for the treatment of cancer, diabetes, rare diseases, multiple sclerosis and cardiovascular diseases; human vaccines for protection against various bacterial and viral diseases; and other products. The company also offers consumer healthcare products for...